199 related articles for article (PubMed ID: 31691976)
1. Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders.
Shomali N; Gharibi T; Vahedi G; Mohammed RN; Mohammadi H; Salimifard S; Marofi F
J Cell Physiol; 2020 May; 235(5):4120-4134. PubMed ID: 31691976
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy.
Gharbavi M; Sharafi A; Ghanbarzadeh S
Curr Gene Ther; 2020; 20(4):269-284. PubMed ID: 32515309
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?
Marofi F; Vahedi G; Hasanzadeh A; Salarinasab S; Arzhanga P; Khademi B; Farshdousti Hagh M
J Cell Physiol; 2019 Feb; 234(2):1268-1288. PubMed ID: 30191962
[TBL] [Abstract][Full Text] [Related]
4. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.
Reiser J; Zhang XY; Hemenway CS; Mondal D; Pradhan L; La Russa VF
Expert Opin Biol Ther; 2005 Dec; 5(12):1571-84. PubMed ID: 16318421
[TBL] [Abstract][Full Text] [Related]
5. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
Xu H; Chen C; Hu L; Hou J
Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of BDNF Gene Recombinant Mesenchymal Stem Cells and Adhesive Peptide-modified Hydrogel Scaffold for Spinal Cord Repair.
Li LM; Huang LL; Jiang XC; Chen JC; OuYang HW; Gao JQ
Curr Gene Ther; 2018; 18(1):29-39. PubMed ID: 29651947
[TBL] [Abstract][Full Text] [Related]
7. Improved therapeutic potential of MSCs by genetic modification.
Wei W; Huang Y; Li D; Gou HF; Wang W
Gene Ther; 2018 Dec; 25(8):538-547. PubMed ID: 30254305
[TBL] [Abstract][Full Text] [Related]
8. Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration.
Santos JL; Pandita D; Rodrigues J; Pêgo AP; Granja PL; Tomás H
Curr Gene Ther; 2011 Feb; 11(1):46-57. PubMed ID: 21182464
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells in drug/gene delivery: implications for cell therapy.
Greco SJ; Rameshwar P
Ther Deliv; 2012 Aug; 3(8):997-1004. PubMed ID: 22946432
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.
Bao Q; Zhao Y; Niess H; Conrad C; Schwarz B; Jauch KW; Huss R; Nelson PJ; Bruns CJ
Stem Cells Dev; 2012 Sep; 21(13):2355-63. PubMed ID: 22530882
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
[TBL] [Abstract][Full Text] [Related]
12. Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI.
Shahror RA; Wu CC; Chiang YH; Chen KY
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516998
[TBL] [Abstract][Full Text] [Related]
13. Programming hMSCs into Potential Genetic Therapy in Cancer.
Serakinci N; Cagsin H
Crit Rev Eukaryot Gene Expr; 2019; 29(4):343-350. PubMed ID: 31679295
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells: an emerging tool for cancer targeting and therapy.
Fritz V; Jorgensen C
Curr Stem Cell Res Ther; 2008 Jan; 3(1):32-42. PubMed ID: 18220921
[TBL] [Abstract][Full Text] [Related]
15. Possibilities and efficiency of MSC co-transfection for gene therapy.
Christoffers S; Seiler L; Wiebe E; Blume C
Stem Cell Res Ther; 2024 May; 15(1):150. PubMed ID: 38783353
[TBL] [Abstract][Full Text] [Related]
16. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
[TBL] [Abstract][Full Text] [Related]
17. A Novel Approach for Image-Guided
Schug C; Gupta A; Urnauer S; Steiger K; Cheung PF; Neander C; Savvatakis K; Schmohl KA; Trajkovic-Arsic M; Schwenk N; Schwaiger M; Nelson PJ; Siveke JT; Spitzweg C
Mol Cancer Res; 2019 Jan; 17(1):310-320. PubMed ID: 30224540
[TBL] [Abstract][Full Text] [Related]
18. Potential implications of mesenchymal stem cells in cancer therapy.
Dai LJ; Moniri MR; Zeng ZR; Zhou JX; Rayat J; Warnock GL
Cancer Lett; 2011 Jun; 305(1):8-20. PubMed ID: 21396770
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.
Moradian Tehrani R; Verdi J; Noureddini M; Salehi R; Salarinia R; Mosalaei M; Simonian M; Alani B; Ghiasi MR; Jaafari MR; Mirzaei HR; Mirzaei H
J Cell Physiol; 2018 May; 233(5):3831-3845. PubMed ID: 28703313
[TBL] [Abstract][Full Text] [Related]
20. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
